Paxlovid (IMAGE)
Caption
Epidemiology researchers have found that if just 20 percent of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs.
Credit
University of Texas at Austin
Usage Restrictions
None
License
Licensed content